Membership is FREE – with unlimited access to all features, tools, and discussions. Premium accounts get benefits like banner ads and newsletter exposure. ✅ Signature links are now free for all. 🚫 No AI-generated (LLM) posts allowed. Share your own thoughts and experience — accounts may be terminated for violations.
Research Corporation Technologies and the Protein Interactions Group of the National Cancer Institute at the National Institutes of Health have published the first studies in primates that characterize the long half-life of isolated CH2 domains, a new antibody-derived scaffold.